CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 109 filers reported holding CYTEK BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,746,806 | -35.4% | 6,657,030 | 0.0% | 0.82% | -32.3% |
| Q2 2023 | $56,851,036 | -19.7% | 6,657,030 | -13.6% | 1.21% | -3.5% |
| Q1 2023 | $70,795,294 | -20.2% | 7,703,514 | -11.3% | 1.26% | -33.0% |
| Q4 2022 | $88,669,051 | -31.2% | 8,684,530 | -0.8% | 1.87% | -44.8% |
| Q3 2022 | $128,903,000 | +37.2% | 8,757,030 | 0.0% | 3.39% | +68.3% |
| Q2 2022 | $93,963,000 | -0.5% | 8,757,030 | 0.0% | 2.01% | +2.2% |
| Q1 2022 | $94,401,000 | -33.9% | 8,757,030 | 0.0% | 1.97% | -10.7% |
| Q4 2021 | $142,915,000 | -23.8% | 8,757,030 | 0.0% | 2.21% | -10.0% |
| Q3 2021 | $187,488,000 | – | 8,757,030 | – | 2.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $30,912,000 | 12.48% |
| Miura Global Management | 820,000 | $12,070,000 | 7.24% |
| RA Capital Management | 13,381,054 | $196,969,000 | 4.20% |
| HHLR ADVISORS, LTD. | 8,757,030 | $128,903,000 | 3.39% |
| Brown Capital Management | 4,406,461 | $64,863,000 | 0.91% |
| Perceptive Advisors | 1,289,534 | $18,982,000 | 0.55% |
| Hillsdale Investment Management Inc. | 344,529 | $5,072,000 | 0.46% |
| PURA VIDA INVESTMENTS, LLC | 527,164 | $7,760,000 | 0.45% |
| Parkwood LLC | 42,336 | $623,000 | 0.09% |
| PDT Partners, LLC | 31,436 | $463,000 | 0.07% |